Welcome to our dedicated page for CALAVO GROWERS SEC filings (Ticker: CVGW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CALAVO GROWERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CALAVO GROWERS's regulatory disclosures and financial reporting.
Calavo Growers Inc director Adriana Mendizabal exercised restricted stock units into common shares. On April 23, 2026, she exercised 4,259 restricted stock units at an exercise price of $0.00 per unit, receiving 4,259 shares of common stock.
After this transaction, she directly holds 15,480 shares of Calavo common stock. Footnotes explain that each restricted stock unit represents a contingent right to receive one share of CVGW common stock and that a separate block of 2,220 restricted stock units relates to common shares whose receipt was previously deferred.
Calavo Growers director Steve Hollister exercised 4,259 restricted stock units, receiving the same number of common shares at a stated price of $0.00 per share. Following the transaction, he directly holds 48,110 shares of Calavo Growers common stock.
Each restricted stock unit represents a contingent right to receive one share of common stock and fully vests on the earlier of the one-year anniversary of the grant date or Calavo Growers’ 2026 annual meeting of shareholders, provided that meeting occurs on or after April 8, 2026.
Mission Produce, Inc. reported that the Hart-Scott-Rodino waiting period for its previously announced merger with Calavo Growers expired at 11:59 p.m. Eastern on April 17, 2026, satisfying one closing condition. The Mergers remain subject to stockholder approvals, Mexican antitrust clearance and other customary closing conditions. The parties expect to close in the fiscal quarter ending July 31, 2026. Mission filed a Registration Statement on Form S-4 (declared effective March 20, 2026) and commenced mailing the Joint Proxy Statement/Prospectus on or about March 25, 2026.
Calavo Growers, Inc. reported that the Hart-Scott-Rodino waiting period for its previously announced merger with Mission Produce, Inc. expired at 11:59 p.m. Eastern on April 17, 2026, satisfying one regulatory closing condition. The merger remains subject to Calavo and Mission Produce stockholder approvals and required Mexico antitrust clearance. The parties state they expect to close the integrated two-step transaction in the fiscal quarter ending July 31, 2026, subject to customary closing conditions. Mission Produce filed a Form S-4 that was declared effective on March 20, 2026, and the joint proxy statement/prospectus was mailed on or about March 25, 2026.
Calavo Growers, Inc. reports that the antitrust waiting period under the Hart-Scott-Rodino Act for its planned merger with Mission Produce, Inc. expired at 11:59 p.m. Eastern time on April 17, 2026, satisfying one of the conditions to closing.
The transaction involves a two-step merger in which Calavo will first become a wholly owned subsidiary of Mission Produce and then merge into a Mission Produce subsidiary. Completion of the mergers still depends on approvals from Calavo shareholders, Mission Produce stockholders, and Mexico antitrust authorities, along with other customary closing conditions.
Subject to meeting these requirements, the parties expect to consummate the mergers in the fiscal quarter ending July 31, 2026. The filing also reminds investors that detailed terms and disclosures are contained in Mission Produce’s effective Form S-4 registration statement and the joint proxy statement/prospectus mailed to shareholders.
Calavo Growers, Inc. filed a Current Report to supplement the joint proxy statement/prospectus relating to its proposed merger with Mission Produce. The companies disclosed supplemental background, Jefferies’ valuation analyses and additional detail in response to litigation and shareholder demand letters. The merger consideration is stated as $27.00 per share (VWAP) and $27.15 per share (spot).
The supplement summarizes Jefferies’ selected-public-company and selected-transactions multiples, discounted cash flow results, and certain diligence chronology items. The filing notes pending shareholder lawsuits and demand letters alleging disclosure deficiencies; Calavo and Mission Produce deny the allegations but provided supplemental disclosures voluntarily.
Mission Produce disclosed supplemental proxy/prospectus information about its proposed mergers with Calavo Growers following a Merger Agreement dated January 14, 2026. The company states it is evaluating a potential one-time Mexican transfer tax and currently believes any payment would not exceed $5 million. The supplement reiterates customary forward-looking statement cautions and directs readers to the joint proxy statement/prospectus and registration statement for full details.
Calavo Growers, Inc. updated the timing mechanics of its previously declared quarterly dividend. The Board had declared a quarterly cash dividend of $0.20 per share on common stock, payable on April 29, 2026, to shareholders of record as of April 1, 2026.
On April 13, 2026, the Board amended the dividend record date to April 24, 2026. The dividend amount of $0.20 per share and the payment date of April 29, 2026 remain unchanged. The change was made in connection with Nasdaq notice requirements for dividend actions.
Calavo Growers Inc: The Vanguard Group filed Amendment No. 9 to its Schedule 13G/A reporting 0 shares beneficially owned of Calavo Growers common stock. The filing explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately in reliance on SEC Release No. 34-39538.
The amended filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026, and states Vanguard no longer is deemed to have beneficial ownership of the securities held by those subsidiaries.